US Patent Issued to Sabah Al-Ahmad Center for Giftedness and Creativity, Dasman Diabetes Institute on Nov. 25 for "Identification of microRNA biomarkers for diagnosis and treatment for Sleep Apnea" (Kuwaiti Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,161, issued on Nov. 25, was assigned to Sabah Al-Ahmad Center for Giftedness and Creativity (Safat, Kuwait) and Dasman Diabetes Institute (Dasman, Kuwait).

"Identification of microRNA biomarkers for diagnosis and treatment for Sleep Apnea" was invented by Abdulmohsen Alterki (Kuwait, Kuwait), Fahd Al-Mulla (Kuwait, Kuwait), Jehad Ahmed Abubaker (Kuwait, Kuwait) and Mohamed Abu-Farha (Kuwait, Kuwait).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present subject matter relates to a method of diagnosing and treating sleep apnea in a subject. The method may include determining whether the subject needs a polysomnography by obtaining a biological sam...